Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Therapy||Indication/Tumor Type||Response Type||Profile Response Detail|
|Unknown unknown||Valrubicin||bladder carcinoma in situ||not applicable||detail...|
|Unknown unknown||BCG solution||bladder carcinoma in situ||not applicable||detail...|
|Unknown unknown||Oportuzumab monatox||bladder carcinoma in situ||not applicable||detail...|
|Unknown unknown||Pembrolizumab||bladder carcinoma in situ||not applicable||detail...|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT03091660||Phase III||BCG Tokyo-172 Strain Solution BCG solution||Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer||Recruiting|
|NCT03106610||Phase I||Nivolumab||Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy||Terminated|